OrthoPediatrics KIDS Return on equity
Return on equity at other companies
Other financials
Where this comes from
Calculated from OrthoPediatrics’s reported figures.
Based on trailing twelve months.
The official record: OrthoPediatrics’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →
Ask your AI about OrthoPediatrics's return on equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is OrthoPediatrics's return on equity?
- OrthoPediatrics (KIDS) reported return on equity of -11.6% in Q1 2026.
- How has OrthoPediatrics's return on equity changed year-over-year?
- OrthoPediatrics's return on equity decreased by 2.1% year-over-year, from -11.3% to -11.6%.
- What is the long-term trend for OrthoPediatrics's return on equity?
- Over 4 years (2020 to 2025), OrthoPediatrics's return on equity has grown at a -10.3% compound annual growth rate (CAGR), from -17.5% to -11.3%.
- What does return on equity mean?
- Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.